An inter-laboratory validation of methods of lipidperoxidation measurement in UVA-treated human plasma samples / Breusing Abstract Lipid peroxidation products like malondialdehyde, 4-hydroxynonenal and F 2 -isoprostanes are widely used as markers of oxidative stress in vitro and in vivo . This study reports the results of a multi-laboratory validation study by COST Action B35 to assess inter-laboratory and intra-laboratory variation in the measurement of lipid peroxidation. Human plasma samples were exposed to UVA irradiation at different doses (0, 15 J, 20 J), encoded and shipped to 15 laboratories, where analyses of malondialdehyde, 4-hydroxynonenal and isoprostanes were conducted. The results demonstrate a low within-day-variation and a good correlation of results observed on two different days. However, high coeffi cients of variation were observed between the laboratories. Malondialdehyde determined by HPLC was found to be the most sensitive and reproducible lipid peroxidation product in plasma upon UVA treatment. It is concluded that measurement of malondialdehyde by HPLC has good analytical validity for inter-laboratory studies on lipid peroxidation in human EDTA-plasma samples, although it is acknowledged that this may not translate to biological validity.
Introduction
Biological membranes and plasma lipoproteins all contain signifi cant proportions of polyunsaturated fatty acids (PUFAs), which make them susceptible to oxidative attack by free radicals and results in peroxidation of the fatty acyl chains. Following the generation of peroxyl radicals and hydroperoxides, rearrangement can lead to formation of relatively more stable long-chain oxidation products such as isoprostanes, which have prostaglandin-like structures but are not synthesized by cyclo-oxygenase [1] ; the F2-isoprostane forms (F2-IsoPs) are the most abundant in plasma and urine. Alternatively, peroxyl radicals or endoperoxides may undergo cleavage to release short chain secondary products, often aldehydes, as in the examples of malondialdehyde (MDA), pentanal and 4-hydroxy-2-nonenal (HNE) [2] . Many lipid peroxidation products, both full chain and chain-shortened, have been reported to demonstrate harmful or pro-infl ammatory effects [3 -5] . There are many studies supporting the idea that oxidative stress and specifi cally the oxidative degradation of PUFAs is involved in many pathological processes. Overwhelming evidence has accumulated over the last decade, indicating that oxidation of lipids plays an important role in the development of multiple acute and chronic human diseases like cancer, atherosclerosis and others [6 -8] . While cell membrane lipid peroxidation may lead to loss of viability, altered signalling and tissue dysfunction, in plasma the oxidation of lipoproteins is probably a major contributor to the formation of lipid peroxi dation products and is widely thought to be involved in atherosclerosis. Malondialdehyde (MDA), 4-hydroxy-2-nonenal (HNE) and F2-isoprostanes (F2-IsoPs) are now the most studied products of lipid peroxidation. MDA and HNE are aldehydes that react with a variety of biomolecules, such as proteins, lipids and nucleic acids, and they are thought to contribute to the pathogenesis of human chronic diseases [6] . Furthermore, their relatively long halflife makes them candidates for the propagation of damage to neighbouring cells . F2-IsoPs exert biological actions and may be pathophysiological mediators of diseases [9, 10] ; their formation correlates with a variety of pathological syndromes associated with oxidative stress [11] .
Quantifi cation of lipid peroxidation can be assessed by the detection of products of PUFA peroxidation. Several markers for lipid peroxidation in vitro and in vivo are available [12] and different methods for detection of lipid peroxidation in biological samples have been described for each marker by numerous authors [6, 13, 14] . Previously, the differences in several markers of oxidative stress were investigated using a rodent model of oxidative damage (CCl 4 administration) in the biomarker of oxidative stress study (BOSS), a multi-centre study in which samples were generated in one laboratory and distributed to other laboratories for analysis of each different marker [15] . This study identifi ed plasma MDA and plasma and urinary F2-IsoPs as promising candidates for free radical damage induced by CCl4, especially with analysis by GC/NICI-MS. On the other hand oxidation products of plasma proteins (protein carbonyl, methionine sulphoxide and 3-nitrotyrosine) and leukocyte DNA (comet assay) did not appear to be reliable oxidation markers in this model [15] . Other studies have reported, mainly with respect to analysis of DNA oxidation products, that methods of oxidative stress detection often lack sensitivity and specifi city and might be disturbed by interference coming from related products or over-estimation resulting from the analysis conditions, i.e. artefacts [16 -18] . It is likely that similar problems may affect markers of oxidative damage resulting from lipid peroxidation. In particular, the combination of parameter and method variety, together with unstable analytes, almost certainly contributes to the high variation seen in some published estimates of oxidative damage to biological lipids. Proudfoot et al. [19] have shown that there are wide limits of agreement between the measurement of F2-IsoPs by an enzyme immunoassay and gas chromatography/mass spectrometry, with only 28% of the values within the 95% confi dence limits for the difference. The values for F2-IsoPs reported vary considerably depending on whether total (esterifi ed plus free) or free F2-IsoPs and one or several regioisomers are being measured; e.g. levels of 3 -25 pg/mL were observed with LC-(APCI)-MS/MS for free 8-iso-PGF2 α [20] , whereas values in the range 200 -300 pg/mL for total F2-IsoPs have been found by GC-NICI-MS [21 -24] . Lykkesfeldt [25] compared malondialdehyde values obtained by Abbreviations: BHT , Butylated hydroxytoluene; BSA , Bovine serum albumin; BSTFA , bis-(trimethylsilyl) trifl uoroacetamide; CV inter , Inter-laboratory coeffi cient of variation; CV intra , Intra-laboratory coeffi cient of variation; DNP , 2, DNPH , 2, ELISA ,  GC-NICI-MS , Gas chromatography negative ion chemical ionization mass spectrometry; HNE , HPLC , High performance liquid chromatography; Liquid chromatography mass spectrometry; MDA , Malondialdehyde; ODS , Octadecylsilane; PBS , Phosphate buffered saline; PUFA , Polyunsaturated fatty acid; RP , Reverse phase; TBA , Thiobarbituric acid; TBARS , Thiobarbituric acid reactive substances; TMB , 3, 3 ' , 5, TPP , Triphenylophosphine; UVA , Ultraviolet light A. Free Radic Res Downloaded from informahealthcare.com by Univ Studi Di Torino on 10/15/10
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HPLC with fl uorescence detection and a direct spectrophotometric method and reported an overestimation by spectrophotometry; a similar fi nding had been reported previously for a comparison of MDA and TBARS analysis [26] . This discrepancy may be explained by the fact that HPLC with fl uorescence detection quantifi es only the genuine MDA-(TBA) 2 adduct, whereas the total absorbance of several thiobarbituric acid reactive substances (TBARS) is measured by the direct spectrophotometric method. In many TBA-dependent methods lipid hydroperoxides are also degraded to release MDA during the assay [1] and the measured levels can also be infl uenced by whether acidic hydrolysis is used to release protein-bound MDA. Furthermore, it is likely that the inconsistent results often found in the fi eld of oxidative stress intervention studies might be due to a lack of accuracy and comparability of the available methods for lipid peroxidation detection. It is very important to address this point, in order to understand the implications on studies of oxidative stress where lipid peroxidation parameters are measured.
Although the research reported by the BOSS group provided important information on the potential of various assays of lipid peroxidation to detect free radical damage in a rodent model, there is still a lack of information from studies addressing the inter-laboratory variability of particular lipid peroxidation assays. The present study was carried out to address this issue in human plasma and assess the inter-laboratory and intra-laboratory variation in the measurement of lipid peroxidation. Fifteen laboratories within the European COST Action B35 on ' Lipid peroxidation associated disorders ' undertook a multi-laboratory validation study using human plasma samples that were generated by a single laboratory and distributed to the participating groups. The plasma was oxidized by exposure ex vivo to ultraviolet A irradiation (UVA) at different doses and three separate markers of lipid peroxidation were measured by different methods. The specifi c aims of the study were to investigate the intra-laboratory variability with two different batches of fi ve identical samples; to compare analysis of the same lipid peroxidation product between different laboratories; to investigate which methods had the sensitivity to detect increased levels of lipid peroxidation expected with the two severities of treatment ex vivo .
Materials and methods

Participating groups
A group of 15 laboratories was set up as an initiative within the European COST B35 action on ' Lipid peroxidation associated disorders ' . All the laboratories involved were experienced in the determination of lipid peroxidation and were blinded with regard to the identity of the samples.
Plasma samples
Residual fresh human plasma-EDTA samples of another study were pooled and divided into three batches of ∼ 250 mL. Two of the batches were subjected to UVA irradiation at a dose of 15 or 20 Joule using a UV chamber ' Minitec ' (Dr Groebel UV Elektronik GmbH, Ettlingen, Germany). The UVA irradiation source was a TL15W/05 lamp that emitted an energy spectrum in the UVA region (320 -400 nm). The emitted dose was calculated using a UV-MAT dosimeter system. Each batch was divided into several petri dishes that were irradiated together in the UV chamber and then re-combined after treatment. The third batch was subjected to the same conditions without irradiation ( ' Control ' ). The three fractions were then aliquoted in the required number and sample sizes for the 15 laboratories, with all aliquots in duplicate.
For the measurement of each lipid peroxidation analyte (or for each method where a laboratory used two methods) the laboratories received 15 encoded (blinded) samples randomly distributed consisting of ' Control ' ( n ϭ 5), ' 15J ' ( n ϭ 5) and ' 20J ' ( n ϭ 5). All samples were frozen and stored at Ϫ 80 ° C and shipped on dry ice. Each laboratory received two batches of samples (batch 1 and batch 2) in order to test the day-to-day variation of the laboratories. The samples of batch 2 were only shipped after receiving the results of the fi rst batch in order to enforce separate analytical runs for the two batches. The overall plan of the study is illustrated in Figure 1 . The samples were either stored at Ͻ 70 ° C or were analysed within 2 weeks (Table I ). The analytes are stable at Ϫ 80 ° C for at least 3 -4 months, based on previous experience of the laboratories.
Lipid peroxidation markers
Lipid peroxidation was determined by the different laboratories using MDA ( n ϭ 8), F2-IsoPs ( n ϭ 3) and HNE ( n ϭ 5) as the studied markers. A variety of analytical techniques were employed, which are summarized in Table I together with important assay characteristics.
HPLC analysis of MDA-TBA adduct. Five laboratories (D, E, G, I and L) determined MDA-TBA adducts according to Khoschsorur et al. [27] (laboratories D, G and L), Wong et al. [28] (laboratory E) and Londero and Greco [29] (laboratory I). Briefl y, plasma was mixed with 0.44 M phosphoric acid and 42 mM TBA, incubated in a water bath for 1 h, cooled and diluted 1:1 with alkaline methanol. The supernatant was separated by HPLC on RP C18 columns and fl uorimetric detection was performed with excitation at 515 (G), 525 -527 (D, E) or 532 nm (I) and emission at 550 -553 nm (D, E, G, I), respectively. Laboratory L detected MDA-TBA adduct elution by UV/VIS detection at 533 nm. 1,1,3,3-tetra(m)ethoxypropane hydrolysed with 1% sulphuric acid was used as a standard.
HPLC analysis of MDA-DNP adduct. Two laboratories (C and F) determined MDA-DNP adducts according to Mateos et al. [30] (laboratory C) and Punchard and Kelly [31] (laboratory F). Briefl y, alkaline or acidic hydrolysis of protein bound MDA was achieved by incubating samples with NaOH (C) or HCl (F) in a 60 ° C water bath for 30 -40 min. The protein was precipitated with perchloric acid (C) or trichloroacetic acid (F) and removed by centrifugation. For derivatization, DNPH (5 mM in 2 M HCl) was added to the supernatant and incubated for 20 min (C) or 60 min (F) at room temperature in the dark. MDA was analysed as its 2,4-dinitrophenylhydrazone derivative at 310 nm following separation by HPLC on RP C18 columns. 1,1,3,3-tetraethoxypropane hydrolysed with 1% sulphuric acid was used as a standard.
Spectrophotometric analysis of MDA with 1-methyl-2phenylindole. Laboratory A determined MDA according to Gerard-Monnier et al. [32] . Briefl y, bound MDA was hydrolysed in the presence of butylated hydro xytoluene in acetonitrile, at pH 1 -2 at 60 ° C for 80 min. A fi nal concentration of 10 mM 1-methyl-2-phenylindole (in 3:1 acetonitrile/methanol) was added to each sample. After centrifugation the reaction was started by adding concentrated HCl (one volume of HCl to fi ve volumes of the reaction mixture). After 60 min incubation at 45 ° C, the absorbance of the supernatant was measured at 586 nm. 1,1,3,3-tetramethoxypropane in the range 0.25 -4 μ M was used as a standard.
HNE-His ELISA. The three laboratories H, J and L determined HNE-histidine conjugates based on previously described procedures [33] . Briefl y, samples were added to wells containing 25 mM (J, L)/100 mM (H) carbonate buffer pH 9.6 and incubated overnight in the fridge. The wells were washed with ddH 2 O (J, L) or 0.05% Tween 20 (H), before incubating at room temperature for 3 h with blocking solution (5% fat-free milk powder in ddH 2 O (J, L) or in 5% Tween 20 in PBS (H)). Subsequently they were washed again with water (J, L)/0.05% Tween 20 (H), before addition of anti-HNE-His antibody (H, 1/200; J and L, 1/100 dilution) and incubation for 2 h at room temperature. At the end of this time the wells were washed thoroughly with wash buffer (0.05% Tween-20 in PBS) followed by treatment with 0.1% sodium azide, 1.5% (J, L) or 5% (H) H 2 O 2 in PBS for 30 min to inhibit sample peroxidase activity. After further extensive washing, secondary antibody (HRP-labelled Anti-Mouse IgG at 1/100 dilution (J, L) or 1/500 dilution (H) in PBS containing 1% BSA) was added and incubated for 1 h. After a few washing steps TMB was added. After 5 -10 min (J) or 30 -60 min (H) incubation, the reaction was stopped with H 2 SO 4 and the plate was read at 450 nm. In parallel, a second HPLC analysis of free HNE. Laboratory H determined free HNE as described previously [34] . Briefl y, plasma was mixed with BHT and desferrioxamine corresponding to ∼ 1 mg protein/ml. The sample was then poured onto an Extrelut column and dichloromethane was applied to collect the eluate in a fl ask containing 0.1 M acetate buffer. In order to obtain an aqueous phase dichloromethane was removed with a rotary evaporator not exceeding 20 ° C. The residual aqueous phase was applied to the ODSdisposable pre-conditioned column and the residual sample was rinsed in a fl ask with methanol/water (15:85) and applied to the column. Free HNE was analysed at 223 nm. BSA treated with various amounts of HNE (prepared in house) was used as a standard, in the range 0.25 -10 nmol/mg protein.
HPLC analysis of HNE-1,3-cyclohexandione adduct.
Laboratory I assayed HNE as a fl uorimetric derivative with 1,3-cyclohexandione separated by HPLC with fl uorometric detection with excitation at 380 nm and emission at 445 nm as described previously [35] .
Commercial ELISA for F2-isoprostanes. 8-epi-prostaglandin F 2 α concentration in plasma samples was assayed by BIOXYTECH ® 8-Isoprostane Assay Kit Oxis Research ™ according to the manufacturer ' s instructions following the extraction procedure. Briefl y, 50 μ L of plasma was extracted in chloroform:methanol (2:1 v/v) supplemented with 50 mg/L butylated hydroxytoluene (BHT) and 500 mg/L triphenylophosphine (TPP) cooled to 0 ° C. Following addition of MgCl 2 solution the organic phase was collected and dried under argon. The lipid pellet was dissolved in methanol containing 50 mg/L BHT, alkalized with KOH solution and incubated at 37 ° C for 30 min before acidifying to pH 3. The sample was cleaned fi rst on a C18 column by washes with 1 mM HCl and heptane before eluting with ethyl acetate:heptane (1:1 v/v). After drying with anhydrous sodium sulphate, the liquid was transferred to a silica column and washed with ethyl acetate; bound material was eluted with ethyl acetate:methanol (1:1 v/v) and dried under argon. The sample was dissolved in 100 μ L of the DB buffer included in the assay kit.
Competitive ELISA was performed exactly as in the assay manufacturer ' s protocol.
F2-isoprostane analysis by GC-MS. F 2 -IsoPs (esterifi ed and non-esterifi ed) were analysed according to Wiswedel et al. [24] and as described briefl y below. Esterifi ed lipids were hydrolysed in the presence of 0.1 mM BHT as an antioxidant using KOH at 45 ° C. Thereafter, 9 α ,11 α -PGF 2 α -d 4 was added as an internal standard. The samples were neutralized by addition of HCl to give pH ∼ 2. The samples were extracted twice with ethyl acetate, the combined upper phases were evaporated under nitrogen and the residues were reconstituted in ethylacetate. The prostanoid extract was applied to NH 2 -cartridges equilibrated with n-hexane and then washed successively with n-hexane/ ethyl acetate (30/70, v/v), acetonitrile/water (90/10, v/v) and acetonitrile before elution with ethyl acetate/ methanol/acetic acid (10/85/5, v/v/v). Dried extracts were derivatized with pentafl uorobenzyl-bromide in the presence of N,N -diisopropylethylamine, dried again before silylation with bis -(trimethylsilyl) trifluoroacetamide (BSTFA). F 2 -IsoPs were separated and measured by GC(NICI)-MS (DSQ/Trace GC Ultra, Thermo Fisher Scientifi c, Dreieich, Germany) using a DB 5-MS column (J&W Scientifi c, Folsom, CA). Quantitative analysis was performed using selected ion monitoring of the carboxylate anion [M-181]at m/z 569 and m/z 573 for F 2 -IsoPs and 9 α ,11 α -PGF 2 α -d 4 (internal standard; Cayman Chemicals Co., Ann Arbor, MI), respectively. The internal standard was quantifi ed using a 5-point calibration curve. Each sample contained 0.5 ng of 8-iso-PGF 2 α and either 0.05 ng, 0.250 ng, 0.50 ng, 1.0 ng and 2.5 ng of 9 α ,11 α -PGF 2 α -d 4 .
F2-isoprostane analysis by LC-MS. 8-iso-prostaglandin F 2 α (8-isoPGF 2 α ) was assayed by LC-MS essentially using the method of Coolen et al. [36] . The fi rst step of sample preparation was alkaline hydrolysis. To extract the 8-iso-PGF 2 α , the samples were purifi ed by using SEP-PAK C18 column containing octadecylsilyl silica gel (Waters Associates, Milford, MA, USA). 8-isoPGF 2 α was separated by HPLC and detected using electrospray ionization mass spectrometry. The separation was carried out on RP C18 with a linear gradient from 100% water adjusted to pH 5.7 with acetic acid to 100% acetonitrile. 8-isoPGF 2 α in the range 1 -1000 pg/mL was used as a standard.
Statistics
Data were analysed using Statistica (StatSoft, Tulsa, OK) and are represented as mean values with standard deviations. Using the results of the fi ve single measurements in one laboratory, the intra-laboratory coeffi cient of variation (CVintra) was calculated as SD/mean ϫ 100 for the three different treated sample types. Inter-laboratory coeffi cient of variation (CVinter) was calculated for between-laboratory data from each measured parameter, independently to which method was used for the determination of the parameter. Signifi cance of differences between Control-, 15J-and 20J-treated samples was tested using the Student ' s test for dependent samples considering p Ͻ 0.05 as signifi cantly different. Pearson ' s correlation coeffi cients were calculated for relationships between batch 1 and 2 for the different markers.
Results
Of the 15 European laboratories participating in the inter-laboratory validation study, nine aimed to perform measurements on one parameter, four laboratories on two parameters and two on three parameters. Due to methodological problems four laboratories reduced their planned measurements by one parameter and one laboratory returned incomplete results. Finally, for the data analysis of the present work the complete data sets of 16 measurements of 12 laboratories (named A to L) were available and used for data analyses. UVA-irradiation was used as the model system, because it represents a well-documented injury that is oxidative in nature [37] .
Intra-laboratory analysis
Intra-laboratory variation (CVintra) for the participating laboratories was calculated for each of the three treatments in both batches (control, 15J and 20J) using the fi ve identical samples in each set. These CVintras represent the within-day-variation of each laboratory. As seen in Table II , CVintra for MDA determination showed a wide range between 1 -175%. In batch 1, two of eight laboratories showed intralaboratory CVs of Ͻ 10%, four of eight Ͻ 20% and one of eight Ͻ 30%. One laboratory was characterized by a CVintra of Ͼ110%. Intra-laboratory CVs in batch 2 were in general higher than in batch 1, where again two laboratories showed CVintras Ͻ 10%. However, calculated intra-laboratory CVs were, except for two laboratories, comparable between the three sample types. The CVintra for F2-IsoPs and HNE also showed a wide range between 6 -112% for F2-IsoPs and 9 -136% for HNE (Tables III and IV) . In contrast to MDA, CVintra of these parameters were characterized by greater differences between the two batches and less consistent CVs within the individual laboratories.
In order to study the day-to-day variation in the laboratories, correlation coeffi cients between batch 1 and batch 2 were calculated for all three lipid peroxidation parameters. Correlation analysis indicated a strong statistically signifi cant positive correlation between results of batch 1 and batch 2 for MDA ( r ϭ 0.82) and F2-IsoPs ( r ϭ 0.93), as shown in Figure 2 ; there was also a weak but signifi cant correlation for HNE ( r ϭ 0.62).
In an additional experiment, one laboratory (laboratory L) performed the determination of MDA and HNE in the same 15 samples. Figure 3 shows the measured MDA and HNE results in ascending order within each treatment set. Interestingly, for MDA the fi ve lowest concentrations were found in the control samples as expected. There was a tendency for the values to increase with increasing irradiation, although the distinction between the 15J and 20J sets is not clear. The values for HNE generally showed a similar pattern within each treatment set, although the values were slightly more variable. In particular, there was no clear trend to higher values with increased severity of treatment, demonstrating a low specifi city of this HNE method for detecting oxidative damage to lipids in plasma. It should be noted that the values of the MDA and HNE cannot be directly compared, as the HNE analyses are expressed as nanomols of HNE per mg of protein (i.e. the extent of protein modifi cation within the sample), rather than as an absolute concentration for HNE.
Inter-laboratory analysis
Mean, SD, median and CVinter of MDA, F2-IsoPs and HNE measurements are presented in Table V . The inter-laboratory coeffi cient of variation for all three markers was calculated to be very high and ranged from 63 -190% (Table V) , with the inter-laboratory CVs of HNE detection being highest and of MDA detection lowest. A comparison of the data for all three lipid peroxidation analytes and all treatments between batch 1 and batch 2 showed that the means and medians were in almost all cases lower in batch 2, by as much as 5-fold for some sets of data. Due to the high inter-laboratory variation, a statistically signifi cant increase of lipid peroxidation could not be found in the oxidized samples, neither in batch 1 nor in batch 2 (Table V, p Ͼ 0.05).
The mean values of each laboratory for MDA ' control ' samples of batch 1 are presented in Figure 4 in ascending order with the median value of 1.11 μ mol/L indicated. A factor of 49 separates the highest and lowest values. Only two of the eight laboratories were within Ϯ 50% of the median of MDA control samples, whereas four laboratories were within Ϯ 50% of the median observed in both UVAtreated samples (data not shown), demonstrating that the variation of the results might be affected by the state of oxidation. Interestingly, the highest values for MDA were determined in laboratories using a method other than TBA-adduct detection by HPLC (Figure 4 ). The median for MDA detection by HPLC was calculated to be 0.55 μ mol/L for MDA control samples. It was also observed that the mean values of ELISA-based HNE-His detection ( n ϭ 3) were up to 20-fold higher than mean values for chromatographic methods ( n ϭ 2; Table VI) .
Potential for detection of UVA-induced lipid peroxidation
An important aspect of the study was to test whether the levels of lipid peroxidation products assayed were able to distinguish and predict correctly the induced lipid peroxidation, according to the severity of the irradiation dose. With regard to MDA determination, fi ve out of eight laboratories showed a signifi cant and progressive increase in MDA in 15J and 20J-treated samples ( Figure 5A ). These results are in contrast to those of F2-isoprostane and HNE determinations, in which there are only partial signifi cant differences or no signifi cant differences ( Figures 5B and C) . It was further shown that the simultaneous determination of HNE-His by ELISA (H-1 in Figure 5C ) and HPLC (H-2 in Figure 5C ) in one laboratory (H) resulted in different HNE concentrations (18-fold for ' 20J ' samples).
Further analyses tested whether differences in lipid peroxidation can also be observed if data of all laboratories were used, and the result is shown in Figure 6 . There was no statistically signifi cant rise in MDA, F2-IsoPs and HNE when the data of all laboratories were analysed together. However, the observed changes of HNE were characterized by a very high variation ( ∼ 3-fold mean value).
Discussion
Besides the quantifi cation of inter-laboratory variations in the determination of lipid peroxidation markers, we were interested to assess the contribution of intralaboratory variation to inter-laboratory variation. Our data for MDA measurements indicate low within-day variances characterized by intra-laboratory CVs between 1 -30% in most of the laboratories. There was one laboratory that had serious diffi culties in yielding similar and reproducible results, highlighted by the fact that intra-laboratory CVs for the different sample types ranged between 110 -175%; the method used in this case was the DNPH-HPLC analysis of MDA. Within-day variances for HNE and F2-IsoP were characterized by higher within-day variances and less consistency within the single laboratories compared to MDA measurements.
To investigate if the laboratories are able to reproduce their results, identical samples were analysed for second time coded to the laboratories as batch 2 representing the day-to-day variance of the laboratories. We observed a good correlation between the results observed in batch 1 and 2, with correlation coefficients of 0.82 for MDA and 0.93 for F2-IsoP. A statistically signifi cant but only weak correlation was found for HNE. The samples of the second batch were older at the time of measurement than samples of batch 1 (as all the samples were derived from one Figure 2 . Results of correlation analyses between batch 1 and batch 2 for MDA, F2-isoprostanes and HNE determination. Correlation coeffi cients and p -values are presented. Figure 3 . Results of an intra-laboratory comparison of two methods for lipid peroxidation: MDA detection with TBA-HPLC and HNE detection by ELISA. Measurements were carried out on 15 samples in total for each analyte, fi ve for each of the three treatments (control, 15J, 20J). Results of MDA and HNE analysis were both arranged in order of increasing values found within each treatment set; note that the sample sets for the two analytes are separate (10 separate equivalent aliquots per treatment). original plasma pool), which raises the possibility of either an increase in lipid peroxidation due to longer storage and a decrease due to degradation processes. As the absolute values (median) of all markers in samples of the second batch are slightly lower compared to those of batch 1 and there was increased variability, the occurrence of degradation processes seems most likely.
Malondialdehyde, 4-Hydroxy-2-nonenal and F2-Isoprostanes have been extensively used during recent years as markers of lipid peroxidation. However, different analytical methods established for each of these parameters generate the problem of inconsistent results, either due to method specifi city or sensitivity. Furthermore, oxidative stress markers are by nature easily prone to over-estimation if stringent precautions are not taken in sample handling and storage. For example, high temperature and low pH during the reaction of MDA with TBA may cause artefactual formation of lipid peroxidation products. Consequently, some of what is measured in the fi eld of lipid peroxidation studies may in fact be artifact. Thus, quantifi cation of lipid peroxidation can be misleading and the range might further be increased by an expected high variance between laboratories and analytical methods. Since there is a lack of knowledge in the literature about the variation in the measurement of lipid peroxidation markers, especially between laboratories, the aim of the present validation study was to quantify intra-and interlaboratory variation in the determination of lipid peroxidation. Varied protocols in the participating laboratories for analysis of each lipid peroxidation compound were intentionally allowed, in order to mimic the real situation in oxidative stress research.
As expected, the reported values for the lipid peroxidation markers measured in this group of COST B35 laboratories were characterized by a high variability between laboratories, illustrated by the fact that inter-laboratory CVs were up to 190%. Thus, it appears that there was very limited agreement of the different methods in terms of detection of each parameter. Interestingly, MDA determinations in eight laboratories performed by both different HPLC methods and one colourimetric method showed the lowest inter-laboratory variations. This fi ts with the observation that, in general, recent measurement of MDA in human plasma of healthy volunteers using TBA falls into a relatively narrow concentration range ∼ 1 -5 μ mol/L [38 -42] , although in some cases lower values have been reported [43] . Interestingly, the highest values for MDA were found using 1-methyl-2-phenylindole as the reagent, probably because this method involves an acid hydrolysis step that releases protein-bound MDA, a signifi cant form of MDA in plasma [32] . Likewise, chromatographic separation V. Mean, standard deviation (SD), median and inter-laboratory coeffi cient of variation in two independent (batch 1 and 2) measurements of Malondialdehyde ( n ϭ 8), F2-isoprostanes ( n ϭ 3) and 4-Hydroxy-2-nonenal ( n ϭ 5 with UV detection of the MDA-DNP adduct, which also measures both free and protein-bound MDA, resulted in absolute concentrations of MDA 2 -4.5fold higher than the median of the chromatographic detection with TBA. In fact, the four laboratories (D, E, G, I) that carried out MDA analysis by TBA-HPLC gave the most closely matching profi les, although the absolute values still showed considerable variation. These fi ndings support the theory that the use of different methods contributes to the broad range reported here.
In our group of laboratories, HNE and F2-IsoP determinations were conducted by two and three methods, respectively, and particularly the high variations in HNE values between the fi ve involved laboratories suggests serious problems, either in the analytical methods or in sample handling. However, sample handling and method variation probably contributes to the variability for MDA also, although this method seems to be more robust. Since it was reported by the laboratories performing HNE-ELISA that the concentrations analysed bordered on the detection threshold of the method and were in the range of the two lowest standards, it appears that the present method is not yet optimal for the analysis of HNE-protein adducts in EDTA-plasma exposed to UVA, possibly because the extent of peroxidation obtained after UVA treatment was low. The HNE-His ELISA used was developed for analysis of cultured cells and cell lysates and has not yet been adapted specifi cally for HNE-His determinations in the human plasma samples. This study represents the fi rst time that the HNE-His ELISA has been tested in oxidized plasma; previously only HNE spiking of EDTAplasma was tested and found to give 90% recovery. The methods used for F2-isoprostanes all involved an alkaline hydrolysis step and therefore measured both free and phospholipid-esterifi ed isoprostanes in the plasma. However, in GC-NICI-MS the analysis is based on one gas chromatographic peak that contains 4 regioisomers, whereas in LC-MS the regioisomers can be separated and 8-iso-PGF2 α quantifi ed; the ELISA method similarly detects only 8-iso-PGF2 α . This in part explains the higher values from the the potential to refl ect the lipid peroxidation status in human EDTA-plasma samples subjected to different doses of UVA-irradiation. However, it is also necessary to note that the conclusions from this study in vitro cannot necessarily be extrapolated to the analysis of free radical-induced damage in vivo .
